Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cattle Diseases D002418 24 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Gadelha IC et al. Gossypol toxicity from cottonseed products. 2014 ScientificWorldJournal pmid:24895646
Qian C et al. Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor. 2014 Drug Des Devel Ther pmid:24872679
Kaza N et al. BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. 2014 PLoS ONE pmid:24824755
Mellon JE et al. Growth inhibitory effects of gossypol and related compounds on fungal cotton root pathogens. 2014 Lett. Appl. Microbiol. pmid:24713043
Cho H et al. Polymeric micelles for apoptosis-targeted optical imaging of cancer and intraoperative surgical guidance. 2014 PLoS ONE pmid:24587157
Sonpavde G et al. Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer. 2014 BJU Int. pmid:24298897
Ignatova M et al. Quaternized chitosan-coated nanofibrous implants loaded with gossypol prepared by electrospinning and their efficacy against Graffi myeloid tumor. 2014 J Biomater Sci Polym Ed pmid:24236801
Paulus A et al. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs. 2014 Br. J. Haematol. pmid:24467634
Jang GH and Lee M BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.). 2014 Life Sci. pmid:24625733
Li G et al. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo. 2014 Cell Death Dis pmid:24434521
Mei H et al. Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer. 2014 Neoplasma pmid:24299314
Spijkers-Hagelstein JA et al. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. 2014 Eur. J. Cancer pmid:24703900
Sorokina EV et al. [Influence of immunovac-VP-4 therapy on innate immunity effectors in patients with darier erythema annulare centrifugum]. 2013 Nov-Dec Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:24605681
Lin YL et al. Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells. 2013 Mol. Pharm. pmid:23734725
Pond GR et al. Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials. 2013 Urol. Oncol. pmid:22552048
El-Nassan HB Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents. 2013 Eur J Med Chem pmid:23434636
Liu Z et al. Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. 2013 Inflamm. Res. pmid:23435932
Pridgeon JW et al. Attempt to develop live attenuated bacterial vaccines by selecting resistance to gossypol, proflavine hemisulfate, novobiocin, or ciprofloxacin. 2013 Vaccine pmid:23499519
Hamdy R et al. Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents. 2013 Bioorg. Med. Chem. Lett. pmid:23474389
Yuan Y et al. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. 2013 Cell Death Dis pmid:23807219
Deng S et al. Gossypol acetic acid induces apoptosis in RAW264.7 cells via a caspase-dependent mitochondrial signaling pathway. 2013 J. Vet. Sci. pmid:23820203
Zhan YH et al. Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone. 2013 Asian Pac. J. Cancer Prev. pmid:23679275
Mellon JE et al. Effects of temperature and medium composition on inhibitory activities of gossypol-related compounds against aflatoxigenic fungi. 2013 J. Appl. Microbiol. pmid:23594138
Cho H et al. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. 2013 J Control Release pmid:23246471
Ahn JH et al. Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol. 2013 J. Cell. Physiol. pmid:23254564
Zhang Z et al. Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach. 2013 Eur J Med Chem pmid:23220642
Xin J et al. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells. 2013 Biomed. Pharmacother. pmid:23201009
Song T et al. 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1. 2013 Bioorg. Med. Chem. pmid:23206987
Cheng P et al. The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells. 2013 Cell Death Dis pmid:23392177
Ni Z et al. Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. 2013 Leuk. Lymphoma pmid:23398207
Huo M et al. Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. 2013 Int. Immunopharmacol. pmid:23352443
Goff DJ et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. 2013 Cell Stem Cell pmid:23333150
Anderson MA et al. BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia. 2013 Leuk. Lymphoma pmid:23339446
Kannan A et al. Effect of feeding of calcium hydroxide-treated or vitamin E-supplemented cottonseed meal on plasma gossypol levels, blood parameters, and performance of Bikaneri lambs. 2013 Trop Anim Health Prod pmid:23345064
Ansari N et al. Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy. 2013 Methods Cell Biol. pmid:23317907
Senarisoy M et al. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks. 2013 Cell Biochem. Biophys. pmid:23161103
Broderick GA et al. Effect of replacing soybean meal protein with protein from upland cottonseed, Pima cottonseed, or extruded Pima cottonseed on production of lactating dairy cows. 2013 J. Dairy Sci. pmid:23462167
Kapoor S Attenuating effect of gossypol on tumor growth in systemic malignancies. 2013 Cell Biochem. Biophys. pmid:23743711
Lin J et al. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. 2013 Oncol. Rep. pmid:23708869
Zhou M et al. Metabolic engineering of gossypol in cotton. 2013 Appl. Microbiol. Biotechnol. pmid:23775273
Song B et al. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. 2013 Immunopharmacol Immunotoxicol pmid:23981004
Billard C BH3 mimetics: status of the field and new developments. 2013 Mol. Cancer Ther. pmid:23974697
Guo JY et al. Effects of high-gossypol cotton on the development and reproduction of Bemisia tabaci (Hemiptera: Aleyrodidae) MEAM1 cryptic species. 2013 J. Econ. Entomol. pmid:23865205
Zhang Z et al. Design and application of a rigid quinazolone scaffold based on two-face Bim α-helix mimicking. 2013 Eur J Med Chem pmid:24095762
Karaca B et al. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. 2013 Mol. Biol. Rep. pmid:23269627
Soderquist R et al. Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo. 2013 Leukemia pmid:23640104
Granchi C et al. Small-molecule inhibitors of human LDH5. 2013 Future Med Chem pmid:24175747
Zhang Z et al. Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors. 2013 Eur J Med Chem pmid:23314054
Zhong S et al. (-)-Gossypol-enriched cottonseed oil inhibits proliferation and adipogenesis of human breast pre-adipocytes. 2013 Anticancer Res. pmid:23482766
Jiao X et al. Comparative transcriptomic analysis of developing cotton cotyledons and embryo axis. 2013 PLoS ONE pmid:23977137